Guardion Health Sciences (NASDAQ:GHSI) Shares Down 6.6%

Guardion Health Sciences Inc (NASDAQ:GHSI) was down 6.6% during trading on Wednesday . The company traded as low as $0.18 and last traded at $0.18, approximately 2,229,555 shares traded hands during mid-day trading. A decline of 43% from the average daily volume of 3,877,539 shares. The stock had previously closed at $0.19.

The company has a quick ratio of 12.66, a current ratio of 13.36 and a debt-to-equity ratio of 0.06. The business has a fifty day simple moving average of $0.24 and a 200 day simple moving average of $0.75.

Guardion Health Sciences (NASDAQ:GHSI) last posted its earnings results on Thursday, November 14th. The company reported ($0.07) earnings per share for the quarter. The firm had revenue of $0.16 million for the quarter. Guardion Health Sciences had a negative return on equity of 186.27% and a negative net margin of 922.62%.

About Guardion Health Sciences (NASDAQ:GHSI)

Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Featured Article: How to Invest in Stocks with Increasing Dividends

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.